Lise Bentzen

Senior Consultant, MD, PhD, Associate Professor Dept. of Oncology, Sygehus Lillebælt, Vejle Sygehus
Research interests

DK: Stråling onkologi, urogenital kræft, HDR-brachyterapi, billedstyret og tilpasningsdygtigt stråleterapi, funktionel elektronisk afbildning i stråleterapi, strålingsinduceret sygelighed, strålebiologi. 

UK: Radiation oncology. Genitourinary cancers. HDR-brachytherapy. Image-guided and adaptive radiotherapy. Functional imaging in radiotherapy. Radiation-induced morbidity. Radiobiology.

 Workgroups Publications
  • Erik B Jørgensen, Gustavo Kertzscher, Simon Buus, Lise Bentzen, Steffen B Hokland, Susanne Rylander, Kari Tanderup, Jacob G Johansen Accuracy of an in vivo dosimetry-based source tracking method for afterloading brachytherapy - A phantom study Med Phys. 2021 May;48(5):2614-2623 2021
  • Erik B Jørgensen, Simon Buus, Lise Bentzen, Steffen B Hokland, Susanne Rylander, Gustavo Kertzscher, Sam Beddar, Kari Tanderup, Jacob G Johansen 3D dose reconstruction based on in vivo dosimetry for determining the dosimetric impact of geometric variations in high-dose-rate prostate brachytherapy Radiother Oncol. 2022 Jun;171:62-68 2022
  • Johansen JG, Rylander S, Buus S, Bentzen L, Hokland SB, Søndergaard CS, With AKM, Kertzscher G, Tanderup K. Time-resolved in vivo dosimetry for source tracking in brachytherapy Brachytherapy. 2018 Jan - Feb; 17(1): 122-132 2018
  • Johansen JG, Kertzscher G, Jørgensen EB, Rylander S, Bentzen L, Hokland SB, Søndergaard CS, With AKM, Buus S, Tanderup K. Dwell time verification in brachytherapy based on time resolved in vivo dosimetry Phys Med. 2019 Apr;60:156-161. 2019
  • Vittrup AS, Tanderup K, Bentzen SM, Jensen NBK, Spampinato S, Fokdal LU, Lindegaard JC, Sturdza A, Schmid M, Segedin B, Jürgenliemk-Schulz IM, Bruheim K, Mahantshetty U, Haie-Meder C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Huang F, Nout RA, Villafranca E, Van Limbergen E, Pieters BR, Tan LT, Lutgens LCHW, Hoskin P, Pötter R, Kirchheiner K; EMBRACE Collaborative Group. Persistence of late substantial patient-reported symptoms (LAPERS) after radiochemotherapy including image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study. Int J Radiat Oncol Biol Phys. 2020 Aug 24;S0360-3016(20)34139-0. 2020
  • Busch K, Andersen AG, Petersen JBB, Petersen SE, Rønde HS, Bentzen L, Pilskog S, Skyt P, Nørrevang O, Muren LP Towards range-guidance in proton therapy to detect organ motion-induced dose degradations Biomed Phys Eng Express . 2022 Feb 18;8(2) 2022
  • Petersen SE, Thorsen LB, Hansen S, Petersen PM, Lindberg H, Moe M, Petersen JB, Muren LP, Høyer M, Bentzen L A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients Acta Oncol . 2022 Feb;61(2):179-184 2022
  • Busch K, Dahl B, Petersen SE, Rønde HS, Bentzen L, Pilskog S, Muren LP Anatomically robust proton therapy using multiple planning computed tomography scans for locally advanced prostate cancer Acta Oncol . 2021 May;60(5):598-604 2021
  • Buus S, Lizondo M, Hokland S, Rylander S, Pedersen EM, Tanderup K, Bentzen L Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI. Brachytherapy. 2018 Jan-Feb;17(1):50-58 2018
  • Pedersen J, Casares-Magaz O, Petersen JBB, Rørvik J, Bentzen L, Andersen AG, Muren LP. A biological modelling based comparison of radiotherapy plan robustness using photons vs protons for focal prostate boosting. Imaging Radiat Oncol. 2018 Jul 18;6:101-105 2018